(Q45331811)

13 December 2017

title

Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study (English)

1 reference

13 December 2017

5

Henk-Jan Guchelaar

1 reference

13 December 2017

Arjen Joosse

1

1 reference

13 December 2017

Elsje R Koomen

2

1 reference

13 December 2017

Mariël K Casparie

3

1 reference

13 December 2017

Ron M C Herings

4

1 reference

13 December 2017

Tamar Nijsten

6

1 reference

13 December 2017

language of work or name

English

0 references

publication date

9 July 2009

1 reference

Journal of Investigative Dermatology

13 December 2017

published in

1 reference

13 December 2017

volume

129

1 reference

13 December 2017

issue

11

1 reference

13 December 2017

page(s)

2620-2627

1 reference

A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Cutaneous malignant melanoma in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

What about chemoprevention for melanoma?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Aspirin, salicylates, and cancer.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Melanoma chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Antioxidant supplementation increases the risk of skin cancers in women but not in men

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Long-term adherence with cardiovascular drug regimens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Age and gender are significant independent predictors of survival in primary cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Validation of pharmacy records in drug exposure assessment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma during malignant melanoma progression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

The puzzle of aspirin and sex

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Cancer research. Anti-inflammatories inhibit cancer growth--but how?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Gender, immunity and the regulation of longevity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Use of cyclooxygenase inhibitors and risk of melanoma in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Molecular basis for the relationship between thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

COX-2 inhibitors in cancer treatment and prevention, a recent development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.201

7 January 2021

Identifiers

DOI

10.1038/JID.2009.201

1 reference

Dimensions Publication ID

13 December 2017

1017790900

0 references

1 reference